陈信光, 张凤祥 . 特定人群室性心律失常风险评估进展及策略[J]. 诊断学理论与实践, 2020 , 19(06) : 549 -554 . DOI: 10.16150/j.1671-2870.2020.06.001
| [1] | Hua W, Zhang LF, Wu YF, et al. Incidence of sudden cardiac death in China: analysis of 4 regional populations[J]. J Am Coll Cardiol, 2009, 54(12):1110-1118. |
| [2] | Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm So-ciety(APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population[J]. Europace, 2020, 22(8):1147-1148. |
| [3] | Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology(AEPC)[J]. Europace, 2015, 17(11):1601-1687. |
| [4] | Schmidt G, Malik M, Barthel P, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction[J]. Lancet, 1999, 353(9162):1390-1396. |
| [5] | Buxton AE, Fisher JD, Josephson ME, et al. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT)[J]. Prog Cardiovasc Dis, 1993, 36(3):215-226. |
| [6] | Disertori M, Masè M, Rigoni M, et al. Heart rate turbulence is a powerful predictor of cardiac death and ventricular arrhythmias in postmyocardial infarction and heart failure patients: a systematic review and meta-analysis[J]. Circ Arrhythm Electrophysiol, 2016, 9(12): e004610. |
| [7] | Morin DP, Zacks ES, Mauer AC, et al. Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy[J]. Heart Rhythm, 2007, 4(7):904-912. |
| [8] | Panza JA, Ellis AM, Al-Khalidi HR, et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy[J]. N Engl J Med, 2019, 381(8):739-748. |
| [9] | Disertori M, Rigoni M, Pace N, et al. Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis[J]. JACC Cardiovasc Imaging, 2016, 9(9):1046-1055. |
| [10] | Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality[J]. Circulation, 2006, 114(1):32-39. |
| [11] | Prystowsky EN, Nisam S. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial[J]. Am J Cardiol, 2000, 86(11):1214-1215,A1215. |
| [12] | Biering-Sørensen T, Olsen FJ, Storm K, et al. Prognostic value of tissue Doppler imaging for predicting ventricular arrhythmias and cardiovascular mortality in ischaemic cardiomyopathy[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(7):722-731. |
| [13] | Bui AH, Cannon CP, Steg PG, et al. Relationship between early and late nonsustained ventricular tachycardia and cardiovascular death in patients with acute coronary syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial[J]. Circ Arrhythm Electrophysiol, 2016, 9(2):e002951. |
| [14] | Køber L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart fai-lure[J]. N Engl J Med, 2016, 375(13):1221-1230. |
| [15] | Kuruvilla S, Adenaw N, Katwal AB, et al. Late gadoli-nium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis[J]. Circ Cardiovasc Imaging, 2014, 7(2):250-258. |
| [16] | Tung R, Bauer B, Schelbert H, et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias:the potential role of occult inflammation in arrhythmogenesis[J]. Heart Rhythm, 2015, 12(12):2488-2498. |
| [17] | Naruse Y, Sekiguchi Y, Nogami A, et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis[J]. Circ Arrhythm Electrophysiol, 2014, 7(3):407-413. |
| [18] | Murtagh G, Laffin LJ, Beshai JF, et al. Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance[J]. Circ Cardiovasc Imaging, 2016, 9(1):e003738. |
| [19] | Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis[J]. JACC Cardiovasc Imaging, 2013, 6(4):501-511. |
| [20] | Aquaro GD, Perfetti M, Camastra G, et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY Study[J]. J Am Coll Cardiol, 2017, 70(16):1977-1987. |
| [21] | Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis[J]. J Am Coll Cardiol, 2014, 63(4):329-336. |
| [22] | van Hare GF, Javitz H, Carmelli D, et al. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes[J]. J Cardiovasc Electrophysiol, 2004, 15(7):759-770. |
| [23] | Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study[J]. Circulation, 2004, 109(16):1994-2000. |
| [24] | Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias[J]. Europace, 2014, 16(9):1257-1283. |
| [25] | Deac M, Alpendurada F, Fanaie F, et al. Prognostic va-lue of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy[J]. Int J Cardiol, 2013, 168(4):3514-3521. |
| [26] | Calkins H, Corrado D, Marcus F. Risk stratification in arrhythmogenic right ventricular cardiomyopathy[J]. Circulation, 2017, 136(21):2068-2082. |
| [27] | Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013[J]. Heart Rhythm, 2013, 10(12):1932-1963. |
| [28] | Anastasakis A, Papatheodorou E, Ritsatos K, et al. Sudden unexplained death in the young: epidemiology, aetio-logy and value of the clinically guided genetic screening[J]. Europace, 2018, 20(3):472-480. |
| [29] | Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy[J]. Eur Heart J, 2013, 34(40):3109-3116. |
| [30] | Hayashi M, Denjoy I, Extramiana F, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia[J]. Circulation, 2009, 119(18):2426-2434. |
| [31] | Adler A, Rosso R, Chorin E, et al. Risk stratification in Brugada syndrome: clinical characteristics, electrocardiographic parameters, and auxiliary testing[J]. Heart Rhythm, 2016, 13(1):299-310. |
| [32] | Sieira J, Conte G, Ciconte G, et al. A score model to predict risk of events in patients with Brugada Syndrome[J]. Eur Heart J, 2017, 38(22):1756-1763. |
| [33] | Yamagata K, Horie M, Aiba T, et al. Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome:a Japanese multicenter registry[J]. Circulation, 2017, 135(23):2255-2270. |
| [34] | Sroubek J, Probst V, Mazzanti A, et al. Programmed ventricular stimulation for risk stratification in the Brugada Syndrome: a pooled analysis[J]. Circulation, 2016, 133(7):622-630. |
/
| 〈 |
|
〉 |
